 |
Rivus Pharmaceuticals
Last updated: August 12, 2024
Allen Cunningham, President and CEO
USA | Funding: $167M (+)
Website: https://www.rivuspharma.com/
Rivus Pharmaceuticals is dedicated to improving metabolic health by developing controlled metabolic accelerators (CMAs) that treat metabolic disorders, including the tricky nonalcoholic steatohepatitis (NASH), cardio-metabolic diseases and obesity, via weight loss.
Website: https://www.rivuspharma.com/
Rivus Pharmaceuticals is dedicated to improving metabolic health by developing controlled metabolic accelerators (CMAs) that treat metabolic disorders, including the tricky nonalcoholic steatohepatitis (NASH), cardio-metabolic diseases and obesity, via weight loss.
